Back to search

University of Crete (UOC)

Πρωτεΐνες που ρυθμίζουν τα επίπεδα και τις λειτουργίες της HDL: νέες προοπικές για τη θεραπεία της καρδιαγγειακής νόσου

Abstract

dc:description

Many studies have shown that HDL has a plethora of functions that may contribute to theprotection from cardiovascular disease. The pathway of the biogenesis and catabolism of HDL isa complex process and involves several membrane bound and plasma proteins. Usingadenoviruses mediated gene transfer in various mouse models, the studies described in thisthesis explore the pathway of the biogenesis of HDL and more specifically the following:1. The importance of the hydrophobic residues in the 218-230 region of apoA-I in thebiogenesis of HDL.2. The effects of LCAT mutations on the biogenesis of HDL.3. The effects of CTα on the biogenesis of HDL.4. The contribution of dominant mutations in apoE to lipid homeostasis and the biogenesisof HDL.5. The synergy of apoA-IV and LCAT on the biogenesis of apoA-IV containing HDL.6. The effect of reconsituted HDL containing apoE and apoA-I on endothelial geneexpression.The importance of the hydrophobic residues in the 218-230 region of apoA-I in the biogenesisof HDLWe have investigated the significance of hydrophobic residues 218-230 on the structureand functions of apoA-I and their contribution to the biogenesis of HDL. We introduced threesets of point mutations in the 218-230 region of apoA-I substituting hydrophobic residues with Alanies. Adenovirus-mediated gene transfer of apoA-I[L218A/L219A/V221A/L222A] in apoA-I-/-mice decreased plasma cholesterol and apoA-I levels to 15% of WT control, and generatedpreβ and α4 HDL particles. In apoA-I-/- x apoE-/- mice the same mutant formed few discoidaland preβ HDL particles that could not be converted to mature α-HDL particles by excessLecithin cholesterol acyltransferase (LCAT). Adenovirus-mediated gene transfer of the apoAI[F225A/V227A/F229A/L230A] mutant in apoA-I-/- mice decreased plasma cholesterol, HDLcholesterol and apoA-I levels. When expressed in apoA-I-/- x apoE-/- mice, approximately 40% ofthe mutant apoA-I as well as mouse apoA-IV and apoB-48 appear in the VLDL/IDL/LDL. In bothmouse models the apoA-I mutant generated small spherical particles of preβ and α4 HDLmobility. Co-expression of the apoA-I mutant and human LCAT increased and shifted the HDLcholesterol peak towards lower densities, created normal α-HDL subpopulations and generatedspherical HDL particles. The apoA-I[218-222] and apoA-I[225-230] mutants had 20% and 31% respectively to promote ABCA1-mediated cholesterol efflux as compared to WT apoA-I. Bothmutants had ~65% of normal capacity to activate LCAT in vitro. Biophysical analyses suggestedthat both mutants affected the structural integrity and plasticity of apoA-I that is necessary fornormal functions. Adenovirus mediated gene transfer of apoAI[L218A/L219A/V221A/L222A/F225A/V227A/F229A/L230A] in apoA-I-/- had a similar phenotypeto apoA-I[L218A/L219A/V221A/L222A] that could not be corrected by excess LCAT. Weconclude that the alteration of the hydrophobic 218-222 residues of apoA-I disrupts apoAI/ABCA1 interactions and promotes the generation of defective preβ particles that fail tomature into α-HDL subpopulations, thus resulting in low plasma apoA-I and HDL. Alterations ofthe hydrophobic residues 225-230 also inhibited the biogenesis of HDL and led to the accumulation of immature preβ and α4 HDL particles, a phenotype that could be corrected byadministration of LCAT.The effects of LCAT mutations and CTα on the biogenesis of HDLWe have investigated the effect of overexpression of CTP:phosphocholinecytidylyltransferase (CTα) as well as LCAT mutants on the biogenesis of HDL in different mousemodels. Adenovirus-mediated gene transfer of human apoA-I along with CTα in apoA-I-/- miceincreased plasma cholesterol and phospholipid levels, mainly due to an increase in the HDLfraction, increased the large size HDL subpopulations and formed spherical HDL particles. Genetransfer of WT LCAT in LCAT-/- mice greatly increased total plasma cholesterol levels mainly dueto increase in HDL cholesterol. In contrast gene transfer of human LCAT carrying the naturalmutations LCAT[T123I] and LCAT[P250S] affected moderately plasma cholesterol levels.Fractionation of plasma by density gradient ultracentrifugation showed that WT LCAT increasedthe plasma apoE and apoA-IV levels and shifted the distribution of apoA-I to lower densities.The LCAT[T123I] and LCAT[P250S] mutants restored partially the presence of apoA-I in theHDL2/HDL3 fraction and in the case of the LCAT[T123I] mutant increased apoE in theVLD/IDL/LDL fractions. The LCAT[T123I] caused a biphasic and LCAT[P250S] a monophasicdistribution of the HDL cholesterol. Deficiency in LCAT is associated with formation of two preβHDL subpopulations and small size α-HDL particles. Gene transfer of the LCAT[T123I] andLCAT[P250S] mutants in LCAT-/- mice generated preβ and α-HDL subpopulations with similarsize whereas treatment with WT LCAT generated α-HDL subpopulations. Co-expression of thethe apoA-I[L159R]Fin or the apoA-I[225-230] with LCAT restored the defective HDL phenotype casued by the mutant apoA-I forms. In contrast, co-expression of LCAT[T123I] and LCAT[P250S]with either of the apoA-I[L159R]Fin or the apoA-I[225-230] only moderately restored the HDLphenotype. We conclude that overexpression of CTα and LCAT promotes the biogenesis of HDLand the mutations in LCAT affect differently the biogenesis of HDL.The contribution of dominant mutations in apoE to lipid homeostasis and the biogenesis ofHDLThe K146N/R147W substitutions in human apoE3 were first described in patients with adominant form of type III hyperlipoproteinemia. The effects of these mutations on the in vivofunctions of apoE were studied by adenovirus mediated gene transfer of the full length and atruncated apoE3[K146N/R147W]-202 mutant using different mouse models. A low dose of adenovirus expressing the apoE3[K146N/R147W] mutant in apoE-/- or apoA-I-/- x apoE-/- miceexacerbated the hypercholesterolemia and increased greatly plasma apoE and triglycerideslevels. In apoE-/- mice the apoE3[K146N/R147W] mutant displaced apoA-I from the VLDL/LDL/HDL region and resulted in the accumulation of discoidal apoE containing HDL particles inplasma. Similar doses of WT apoE3 cleared the cholesterol of apoE-/- mice without induction ofhypertriglyceridemia and promoted formation of spherical HDL particles. A unique feature ofthe truncated apoE3[K146N/R147W]-202 mutant is that it prevented the induction ofhypertriglyceridemia but did not correct the hypercholesterolemia. Other apoE-202 truncatedmutants tested previously did not induce hypertriglyceridemia but correctedhypercholesterolemia. Treatment of apoE-/- mice with apoE3[K146N/R147W] and lipoproteinlipase corrected the hypertriglyceridemia but did not prevent the formation of discoidal HDL.Treatment with LCAT also corrected hypertriglyceridemia normalized the CE/TC ratio of plasmaand generated spherical HDL. The combined data indicate that the K146N/R147W substitutionsin the full length and the truncated apoE3[K146N/R147W] mutant prevent receptor-mediatedremnant clearance. The accumulation in plasma of lipoprotein remnants that contain the fulllength apoE3[K146N/R147W] mutant suggests that this mutant acts as a dominant negativeligand that exacerbates the dyslipidemia and also affects the activity of LCAT thus inhibiting thebiogenesis of HDL.The synergy of apoA-IV and LCAT on the biogenesis of apoA-IV containing HDLWe studied the contribution of LCAT on the biogenesis of apoA-IV containing HDL.Adenovirus-mediated gene transfer of apoA-IV in LCAT-/- failed to show the formation ofspherical and α-migrating HDL particles. Adenovirus-mediated gene transfer of apoA-IV inapoA-I-/- mice did not change plasma lipid levels. ApoA-IV floated predominantly in the HDL3region. Co-expression of apoA-IV and LCAT in apoA-I-/- mice restored the formation of HDL-A-IV.The findings are consistent with a novel function of apoA-IV in the biogenesis of discrete HDL-AIVparticles with the participation of LCAT, and may explain previously reported antiinflammatoryand atheroprotective properties of apoA-IV.The effect of reconsituted HDL containing apoE and apoA-I on endothelial gene expressionWe performed reliminary microarray experimetns in human aortic endothelial cells(HAECs) following treatment of reconstituted HDL containing apoA-I (using phospholipids and cholesterol, designated as rHDLAI+, or phospholipids alone, designated as rHDLAI-) or apoE(rHDLE+ and rHDL-). The bioinformatics analyses showed that the rHDLAI- and rHDLAI+treatments caused the differential expression (over 2-fold change and ≤ 0.05 FDR) in 137 and190 genes respectively. The differentially expressed genes in response to rHDLE3- and rHDLE3+were 198 and 272 respectively. The microarrays data were validated with high throughput qRTPCRbased screening using the dynamic array chips. Pathways of highly interconnected geneswere tentatively identified based the Ingenuity Pathway Analysis (IPA) program and pubmedliterature searches.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fotakis, Panagiotis
  • Φωτάκης, Παναγιώτης

Subjects

dc:subject × 11

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38359

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fotakis, Panagiotis; Φωτάκης, Παναγιώτης. Πρωτεΐνες που ρυθμίζουν τα επίπεδα και τις λειτουργίες της HDL: νέες προοπικές για τη θεραπεία της καρδιαγγειακής νόσου. University of Crete (UOC), 2014. http://hdl.handle.net/10442/hedi/38359